Revelation Biosciences Stock Market Value
| REVB Stock | USD 1.47 0.01 0.68% |
| Symbol | Revelation |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. Anticipated expansion of Revelation directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Revelation Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Revelation Biosciences requires distinguishing between market price and book value, where the latter reflects Revelation's accounting equity. The concept of intrinsic value - what Revelation Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Revelation Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Revelation Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Revelation Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Revelation Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Revelation Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Revelation Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Revelation Biosciences.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Revelation Biosciences on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Revelation Biosciences or generate 0.0% return on investment in Revelation Biosciences over 90 days. Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercializati... More
Revelation Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Revelation Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Revelation Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 35.57 | |||
| Value At Risk | (10.16) | |||
| Potential Upside | 6.84 |
Revelation Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Revelation Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Revelation Biosciences' standard deviation. In reality, there are many statistical measures that can use Revelation Biosciences historical prices to predict the future Revelation Biosciences' volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.53) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | (0.66) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revelation Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Revelation Biosciences February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | (0.65) | |||
| Mean Deviation | 3.97 | |||
| Coefficient Of Variation | (412.12) | |||
| Standard Deviation | 5.74 | |||
| Variance | 32.91 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (1.53) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | (0.66) | |||
| Maximum Drawdown | 35.57 | |||
| Value At Risk | (10.16) | |||
| Potential Upside | 6.84 | |||
| Skewness | (0.92) | |||
| Kurtosis | 3.66 |
Revelation Biosciences Backtested Returns
Revelation Biosciences maintains Sharpe Ratio (i.e., Efficiency) of -0.2, which implies the firm had a -0.2 % return per unit of risk over the last 3 months. Revelation Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Revelation Biosciences' Risk Adjusted Performance of (0.19), coefficient of variation of (412.12), and Variance of 32.91 to confirm the risk estimate we provide. The company holds a Beta of 2.13, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Revelation Biosciences will likely underperform. At this point, Revelation Biosciences has a negative expected return of -1.21%. Please make sure to check Revelation Biosciences' potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and market facilitation index , to decide if Revelation Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.19 |
Very weak predictability
Revelation Biosciences has very weak predictability. Overlapping area represents the amount of predictability between Revelation Biosciences time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Revelation Biosciences price movement. The serial correlation of 0.19 indicates that over 19.0% of current Revelation Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.87 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Revelation Biosciences is a strong investment it is important to analyze Revelation Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revelation Biosciences' future performance. For an informed investment choice regarding Revelation Stock, refer to the following important reports:Check out Revelation Biosciences Correlation, Revelation Biosciences Volatility and Revelation Biosciences Performance module to complement your research on Revelation Biosciences. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Revelation Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.